Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Diabetes Health Center

Font Size

FDA Panel Weighs New Diabetes Drugs

FDA Advisory Committee Considers New Type 2 Diabetes Drugs Onglyza, Liraglutide
WebMD Health News
Reviewed by Louise Chang, MD

April 1, 2009 -- An FDA advisory panel is considering two new drugs to improve blood sugar control in people with type 2 diabetes.

Those drugs, named Onglyza (saxagliptin) and liraglutide, treat high blood sugar (hyperglycemia) in type 2 diabetes patients.

Onglyza, which is taken as a once-daily tablet and is in the same class of drugs as Januvia, is being discussed today by an FDA advisory committee.

In a clinical trial presented last year in Rome, Onglyza trumped a placebo at improving hemoglobin A1c (a gauge of blood sugar control) over the previous two to three months in type 2 diabetes patients who took Onglyza or the placebo along with other diabetes drugs for six months.

The drug companies Bristol-Myers Squibb and AstraZeneca, which are collaborating on Onglyza, are seeking approval for Onglyza as a standalone drug as an adjunct to diet and exercise, and in combination with other diabetes drugs.

Liraglutide, which is given once daily by injection and is in the same class of drugs as Byetta, will be on the advisory panel's agenda on April 2. Liraglutide is made by the drug company Novo Nordisk.

In September 2008, researchers reported in The Lancet that liraglutide was safe and effective, and also helped patients lose weight and lower their blood sugar.

The FDA advisory committee will review data from those trials and consider whether further data about cardiovascular safety are needed for either drug candidate.

Today on WebMD

Diabetic tools
Symptoms, diagnosis, treatment, and more.
woman flexing muscles
10 strength training exercises.
Blood sugar test
12 practical tips.
Tom Hanks
Stars living with type 1 or type 2.
kenneth fujioka, md
Can Vinegar Treat Diabetes
Middle aged person
jennie brand miller

Prediabetes How to Prevent Type 2 Diabetes
type 2 diabetes
food fitness planner